Literature DB >> 32417235

Stroke priorities during COVID-19 outbreak: acting both fast and safe.

Alessandro Pedicelli1, Iacopo Valente2, Fabio Pilato3, Marisa Distefano4, Cesare Colosimo5.   

Abstract

While the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spreads all over the world, the healthcare systems are facing the dramatic challenge of simultaneously fight against the outbreak and life-threating emergencies. In this biological setting, emergency departments and neurovascular teams are exposed to high risk of infection and should therefore be prepared to deal with neurological emergencies safely. The purpose of this article is to analyze the current evidence on COVID-19 in the context of acute ischemic stroke and to describe the model of behavior we are putting into action to maintain the stroke pathway both rapid for the patient and safe for the healthcare professionals. We reserve a specific focus on personal protection equipment, dress code and healthcare professional behavior.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute stroke therapy; Coronavirus; Intervention; Ischaemic stroke; Pandemic; Stroke; Stroke teams; Thrombolysis

Mesh:

Year:  2020        PMID: 32417235      PMCID: PMC7200390          DOI: 10.1016/j.jstrokecerebrovasdis.2020.104922

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


Background

On March 11 2020, the World Health Organization (WHO) defined COVID-19 as a pandemic. On April 02, 896,450 confirmed cases in 204 countries were reported. Coronaviruses are not-segmented, enveloped, positive-sense, single-strand ribonucleic acid viruses, belonging to the Coronaviridae family. Human-to-human transmission occurs primarily via direct contact, through surfaces touch, air droplets or airways diffusion. , The higher risk of transmission is within approximately 1 or 2 meters from the infected person but the minimum distance is still undetermined. Evidences showed that 74% of asymptomatic SARS-CoV-2 positive patients may be infective. Although this background makes healthcare professionals’ job difficult and risky, patients with ischemic stroke still need fast intervention. Since five trials demonstrating the efficacy and safety of mechanical thrombectomy (MT) for the treatment of ischemic strokes due to large vessel occlusion (LVO) have been published,9, 10, 11, 12, 13 the endovascular treatment is now the standard of care for patients presenting within 6 hours from symptoms onset. Also patients who arrives between 6 and 24 hours from symptoms onset can benefit from this treatment if they meet specific neuro-radiological criteria. , The whole process of patient's neurological evaluation, radiological examination and medical or interventional treatment should be carried out in the shortest time to reduce brain damage (the so-called “time-is-brain” concept). , Relying on our experience in a COVID-19-reference and tertiary stroke center, we analyze each step of the acute ischemic stroke (AIS) pathway in order to identify the phases at the highest risk of infection and to simplify, when possible, the diagnostic process. Consequently, we developed an intra-hospital protocol to balance the management of ischemic stroke patients (including the access to time-dependent procedures) and the risk of infection.

COVID-19 and ischemic stroke: a possible link?

A brief report claims the decreasing by 50% of mechanical thrombectomies in Shanghai since the end of January compared with the same period in 2019. Data of our hospital shows no reduction in the number of mechanical thrombectomies performed during the outbreak; conversely, we noted an increase of 88,8% in mechanical thrombectomies when comparing the same period (1th March – 1th April) with 2019. Although this increase could hide a bias due to a natural improvement of the stroke network performances, it goes against the trend of previous evidences. However, this trend is not surprising because ischemic stroke was reported as one of the possible complications to COVID-19. The disease is associated with transiently raised serum concentrations of inflammatory cytokines that cause endothelial dysfunction and increases the procoagulant activity of the blood, which can contribute to the formation of an occlusive thrombus over a ruptured arterial plaque. Another proposed mechanism is cardioembolism from virus-related cardiac injury. Cohorts of patients from three Chinese hospitals showed up to 36% of neurological symptoms , that included dizziness, headache, encephalopathy, anosmia, dysgeusia, muscle injury (detected by elevated creatine kinase) and stroke.

The impact of Covid-19 on ischemic stroke management: from TIA to LVO

Current acute stroke management guidelines recommend designing and implementing public education programs focused on stroke systems, referring acute stroke patients to emergency care and evaluating risk factors for patients presenting with TIA. Since AIS is a time-dependent disease and the treatment effectiveness is mainly related to timely access to the therapy, , current guidelines state that emergency therapy should be administrated quickly avoiding unnecessary and potentially time-consuming procedures. , Before COVID-19 outbreak, stroke guidelines have been universally accepted by clinicians involved in acute stroke. On March 09 2020, the Italian Government imposed national quarantine, restricting movement of population except for necessity, work, and health circumstances, in response to the growing pandemic of COVID-19 in the country. Although healthcare system resources have been shifted towards COVID-19 pandemic, both stroke inpatients and outpatients keep requiring high standard of care.

The role of Telemedicine

In the face of Covid-19, the need to reduce the exposure of doctors and patients is vital, as is ensuring the continuity of care for those who need it. Because hospitals are filling up by infected patients and health workers may be asymptomatic carriers, low risk patients should be discouraged to refer to hospitals whenever possible. To make matters even worse, reports that as many as 100 health care workers at a single institution have to be quarantined at home because of exposure to Covid-19 have raised concern about workforce capacity. Telehealth can be a valuable help to solve these problems. It allows patients who have non–Covid-19 issues to receive consultations without the risk of exposure and quarantined doctors to continue to provide care. A pivotal strategy for virus spreading control is forward triage that is the categorization of patients before they arrive in the emergency department (ED). However, such a strategy needs to be integrated into the actual stroke system hub-and-spoke model. To overcome such a difficult situation, software solutions are being used in some regional healthcare systems, playing a key role in this emergency. Telehealth allows transmission of radiological images and video-assisted neurological examination, preventing unnecessary centralization and supporting spoke decisions (Table 1 ).
Table 1

Telehealth uses in stroke patients: from TIA to LVO

PatientsMain purpose
TIA

Home-based video assisted evaluation

risk factors assessment (ABCD2 score)

AIS without LVO

Support Spoke decision on thrombolysis (whenever indicated)

AIS with LVO

Remote imaging evaluation

Request for MT evaluation

Telehealth uses in stroke patients: from TIA to LVO Home-based video assisted evaluation risk factors assessment (ABCD2 score) Support Spoke decision on thrombolysis (whenever indicated) Remote imaging evaluation Request for MT evaluation The aims of the coming weeks is encouraging the diffusion of telehealth system in still-lacking centers enrolling more patients in our patient portals.

Stroke pathway during COVID-19 outbreak: balancing risks for patients and clinicians

Due to COVID-19 outbreak, self-presentation in emergency room (ER) is highly discouraged because of a potential risk of infection; highly suspected for infection or COVID-19 positive (COVID+) patients should be pre-triaged in a separate box. The approach to patients referred to ER should focus on early recognition of suspected COVID-19 positive cases that require immediate isolation and infection control measures. Current WHO guidelines suggest that once COVID-19 infection is suspected, control measures should be immediately implemented and public health officials notified. However, following current public health official guidelines only a minority of population has already been tested for SARS-CoV-2, mainly due to the reduced availability of these tests. , Commonly used tests require several hours for the results and therefore cannot provide useful information for the management of stroke patients in the ER setting. Consequently, to assess the likelihood of infection, risk factors for COVID-19 disease should be taken into consideration. Even if diagnostic criteria are still debated, WHO clinical criteria for pursuing COVID-19 diagnostic evaluation are commonly used. According to WHO, COVID-19 should be considered in patients with fever and/or respiratory tract symptoms (eg, cough, dyspnea) who have had any of the following in the prior 14 days: Close contact with a confirmed or suspected case of COVID-19, including through work in health care settings. Close contact includes being within approximately two meters of a patient for a prolonged time or having direct contact with infectious secretions while not wearing personal protective equipment (PPE). Residence in (or travel to) areas where widespread community transmission has been reported. Potential exposure through attendance at events where COVID-19 cases have been reported. In suspected cases, the epidemiological link to a probable or confirmed case may have occurred within a 14‐day period before the symptoms onset. According to WHO's criteria, we developed a risk stratification table to assess infective risk of patients referred to ER (Table 2 ).
Table 2

Risk stratification, symptoms and characteristics.

Low risk

Neither fever nor respiratory tract symptoms (eg, cough, dyspnea)

No close contact with a confirmed or suspected case of COVID-19

No residence in (or travel to) areas or attendance at events where widespread community transmission has been reported

Intermediate risk

Fever and/or respiratory tract symptoms (eg, cough, dyspnea) with:

No close contact with a confirmed or suspected case of COVID-19

No residence in (or travel to) areas or attendance at events where widespread community transmission has been reported

High risk

Fever and/or respiratory tract symptoms (eg, cough, dyspnea) who have had any of the following in the prior 14 days:

Close contact with a confirmed or suspected case of COVID-19

Residence in or travel to areas or attendance at events where widespread community transmission has been reported

Risk stratification, symptoms and characteristics. Neither fever nor respiratory tract symptoms (eg, cough, dyspnea) No close contact with a confirmed or suspected case of COVID-19 No residence in (or travel to) areas or attendance at events where widespread community transmission has been reported Fever and/or respiratory tract symptoms (eg, cough, dyspnea) with: No close contact with a confirmed or suspected case of COVID-19 No residence in (or travel to) areas or attendance at events where widespread community transmission has been reported Fever and/or respiratory tract symptoms (eg, cough, dyspnea) who have had any of the following in the prior 14 days: Close contact with a confirmed or suspected case of COVID-19 Residence in or travel to areas or attendance at events where widespread community transmission has been reported The WHO has warned that the severe shortage of the global supply of PPE – caused by rising demand, panic buying, and misuse – is putting lives at risk from the novel coronavirus. Then, although clinicians involved in management of AIS patients are at risk of infection and require specific PPE (Table 3 ), they are requested to optimize PPE use and to avoid useless waste. Common hygienic habits such as washing hands with soap and water or alcohol-based hand rub before and after all patient interaction, contact with potentially infectious sources, and before putting on and upon removal of PPE, have to be put into practice.
Table 3

Personal Protective Equipment: level of precaution.

A) Standard precautionB) Contact and droplet precautionC) Airborne precaution
All patients (regardless of the risk) must wear a disposable surgical mask

Disposable surgical cap

Disposable surgical mask

Work uniform

Disposable latex gloves

Disposable surgical cap

Disposable surgical mask

Work uniform

Disposable latex gloves

+

Disposable medical protective uniform

Goggles

Disposable surgical cap

Medical protective mask N95/FFP2 instead of Disposable surgical mask

Work uniform

Disposable latex gloves

+

Water-resistant disposable medical protective uniform

+

Full-face protective devices

Notes: 1. When health care workers put on a disposable particulate respirator, they must always perform the seal check. Note that facial hair (e.g. a beard) may prevent a proper respirator fit.36

ABBREVIATION: FFP2: Filtering Face Piece 2

Personal Protective Equipment: level of precaution. Disposable surgical cap Disposable surgical mask Work uniform Disposable latex gloves Disposable surgical cap Disposable surgical mask Work uniform Disposable latex gloves Disposable medical protective uniform Goggles Disposable surgical cap Medical protective mask N95/FFP2 instead of Disposable surgical mask Work uniform Disposable latex gloves Water-resistant disposable medical protective uniform Full-face protective devices Notes: 1. When health care workers put on a disposable particulate respirator, they must always perform the seal check. Note that facial hair (e.g. a beard) may prevent a proper respirator fit.36 ABBREVIATION: FFP2: Filtering Face Piece 2 Neurovascular team should wear opportune disposable equipment (Table 4 ).
Table 4

Suggested Personal Protective Equipment's classes according to patient's risk and stroke pathway's phase.

RiskPhase
Triage – Neurological evaluationDiagnostic imagingAngiography
LowAAA
IntermediateBBC
HighBCC
COVID-19 +CCC
Suggested Personal Protective Equipment's classes according to patient's risk and stroke pathway's phase.

Diagnostic imaging

According to the AHA / ASA, patients with suspected stroke need brain computed tomography (CT), computed-tomography angiography (CTA) and, in selected cases, computed tomography perfusion (CTP).

How to safely do a CT examination

It is highly recommended to have a CT room dedicated to intermediate-to-high risk or COVID+ patients (Table 2). This room should have a dedicated access route separated from the other areas of the radiology unit and must have, on the ground of the entrance, a cloth soaked in sodium hypochlorite. Two radiologic technologists (RT) should be employed for the CT scanning of patients with intermediate-to-high risk or COVID+ patients. One RT (RT1) uses PPE to set up the patient on the CT table while the other RT (RT2) operates on the CT console (Table 4). CT examination should be performed following a previously described procedure 37: RT1 and the accompanying medical doctor (MD), both equipped with adequate PPE, set up the patient on the CT table and then remove their contaminated PPE and put them into a dedicated garbage inside the room. Then, they leave the CT room. While RT2 operate on the CT scan, RT1 and MD wear a new pair of PPE and, once the examination is over, they transfer the patient from the CT table to the bed. In patients referred from spoke center for LVO, this step could be avoided and the patient could be directly transferred to the angio suite, if all these conditions are satisfied: patient's arrival time within 6 hours from symptoms onset. radiological imaging acquired within the previous two hours at the spoke center; availability of a CT-capable angiograph to rule out hemorrhage; This indication comes from the idea that patients who arrive to the hub center (following the drip-and-ship model) within 7.3 hours of time last seen well, the repetition of the brain imaging before angiography could be unnecessary, but it is still debated. However, in these epidemiological setting, we follow this more rapid approach. A special mention is required for acute stroke patients who are confused, aphasic or unable to provide information for a comprehensive COVID-19 screening. Although these patients should be treated as potentially infected, such an approach is hardly possible due to shortage of PPE. In these cases, an extension of the CT examination to the chest should be taken into consideration to exclude signs of interstitial pneumonia. If pulmonary CT scan exclude signs of interstitial pneumonia, patients could be identified as low-risk and all the remaining procedure could be performed with class A precautions (Table 2). Conversely, if pulmonary CT scan shows signs of interstitial pneumonia, the patient should be considered as high risk and PPE should be used accordingly (Table 4).

Angiography suite

The angiography suite is the place where mechanical thrombectomy is performed. This procedure should be performed in an adequately ventilated room: natural ventilation with air flow of at least 160 L/s per patient or in negative-pressure rooms with at least 12 air changes per hour and controlled direction of air flow when using mechanical ventilation. Since mechanical thrombectomy may require patient intubation (that is classified as an aerosol-producing procedure), intermediate-to-high risk patients need airborne precautions , and all healthcare workers must wear proper protection (Tables 4). The access to the angio suite should be allowed only through one door (“Patient” in Figure 1 ); in front of this door, on the ground, a cloth soaked in sodium hypochlorite should be placed (CL in Figure 1). Both the ray tube and the detector should be covered with a single-use plastic coverage.
Fig. 1

Angio Suite – medical devices: storage and claiming.MD: medical doctor; N1: nurse n.1; N2: nurse n.2; D1: device stored within the angio suite cupboard; D2: device stored within the depot; G: contaminated PPE dedicated garbage; CL: cloth soaked with sodium hypochlorite; C: cart located outside the angio suite; RT: radiologist technician; “Patient”: patient's entrance door; “Staff”: staff's exit door.

Angio Suite – medical devices: storage and claiming.MD: medical doctor; N1: nurse n.1; N2: nurse n.2; D1: device stored within the angio suite cupboard; D2: device stored within the depot; G: contaminated PPE dedicated garbage; CL: cloth soaked with sodium hypochlorite; C: cart located outside the angio suite; RT: radiologist technician; “Patient”: patient's entrance door; “Staff”: staff's exit door. In many hospitals, not all the medical devices required for mechanical thrombectomy are stored inside the angio suite: devices that are rarely used are kept in depots outside the room. Before patient arrival, the availability of the necessary devices should be checked. However, devices needed to do a mechanical thrombectomy can vary from case to case; therefore, it is not possible to foresee (and prepare) all the devices needed before starting the procedure and a behavioral model is needed to allow quick and safe access to all the necessary tools. Following the scheme illustrated in Figure 1, we hypothesized a way of working that involves two nurses: N1 and N2. N1 is intended to be inside the angio suite, wearing appropriate PPE. When a device (D1) is needed, N1 wears a third pair of gloves and takes it from the cupboard; after delivering the material to the first operator, the third pair of gloves will be removed. If the requested device is in the depot (D2), N2 put it on a cart (C) placed outside the entrance door and N1 repeats the above-mentioned procedure.

Decontamination

At the end of the intervention, the undressing of the staff must take place inside the angio suite and near an exit door (preferably a different door from the one used for the patient's exit) (“Staff” in Figure 1); near this door, a dedicated garbage (G) must be set up for the collection of contaminated waste.

Acute stroke: in-hospital management

At the end of acute treatment, patient is admitted to a dedicated ward, according to clinical conditions and infective risk. In our hospital, to limit virus diffusion and provide adequate level of care, we have provided separate wards dedicated to COVID+ and non-COVID+ patients both for those who need intensive care and for those who need sub intensive care.

Shortage of Intensive Care Units beds: the unsolved problem of decompressive hemicraniectomy

A particular evaluation should be done for patients with extensive middle cerebral artery (MCA) territory infarct. MCA occlusion can produce a large brain injury and swelling that may increase intracranial pressure causing malignant brain edema and brain herniation.42, 43, 44 Some studies demonstrated that early decompressive hemicraniectomy (DHC) in patients up to 60 years reduces mortality and improves functional outcome 45, 46, 47, 48; however, several surviving patients remain severely dependent 45, 46, 47, 48 and the ideal candidate for DHC and timing of DHC is still a matter of debate. After COVID-19 outbreak, due to the shortage of intensive care units beds and the allocation of the intensive care resources, DHC should be thoughtfully weighted on a case by case basis.

Conclusion

Having regard to the rapid spreading of the COVID-19, many hospitals will soon have to develop internal protocols to deal with this emergency and to cope with the associated challenging circumstances.

Declaration of Competing Interest

Nothing to declare
  36 in total

1.  Virtually Perfect? Telemedicine for Covid-19.

Authors:  Judd E Hollander; Brendan G Carr
Journal:  N Engl J Med       Date:  2020-03-11       Impact factor: 91.245

2.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

3.  A randomized trial of intraarterial treatment for acute ischemic stroke.

Authors:  Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel
Journal:  N Engl J Med       Date:  2014-12-17       Impact factor: 91.245

4.  Randomized assessment of rapid endovascular treatment of ischemic stroke.

Authors:  Mayank Goyal; Andrew M Demchuk; Bijoy K Menon; Muneer Eesa; Jeremy L Rempel; John Thornton; Daniel Roy; Tudor G Jovin; Robert A Willinsky; Biggya L Sapkota; Dar Dowlatshahi; Donald F Frei; Noreen R Kamal; Walter J Montanera; Alexandre Y Poppe; Karla J Ryckborst; Frank L Silver; Ashfaq Shuaib; Donatella Tampieri; David Williams; Oh Young Bang; Blaise W Baxter; Paul A Burns; Hana Choe; Ji-Hoe Heo; Christine A Holmstedt; Brian Jankowitz; Michael Kelly; Guillermo Linares; Jennifer L Mandzia; Jai Shankar; Sung-Il Sohn; Richard H Swartz; Philip A Barber; Shelagh B Coutts; Eric E Smith; William F Morrish; Alain Weill; Suresh Subramaniam; Alim P Mitha; John H Wong; Mark W Lowerison; Tolulope T Sajobi; Michael D Hill
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

5.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

6.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

Authors:  Shaobo Shi; Mu Qin; Bo Shen; Yuli Cai; Tao Liu; Fan Yang; Wei Gong; Xu Liu; Jinjun Liang; Qinyan Zhao; He Huang; Bo Yang; Congxin Huang
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

7.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.

Authors:  Yanan Li; Man Li; Mengdie Wang; Yifan Zhou; Jiang Chang; Ying Xian; David Wang; Ling Mao; Huijuan Jin; Bo Hu
Journal:  Stroke Vasc Neurol       Date:  2020-07-02

8.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

View more
  5 in total

Review 1.  Smartphone App in Stroke Management: A Narrative Updated Review.

Authors:  Adriano Bonura; Francesco Motolese; Fioravante Capone; Gianmarco Iaccarino; Michele Alessiani; Mario Ferrante; Rosalinda Calandrelli; Vincenzo Di Lazzaro; Fabio Pilato
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

2.  Multiple Acute Ischemic Strokes in a COVID-19 Patient: a Case Report.

Authors:  Davide Cerasti; Francesca Ormitti; Stefano Pardatscher; Laura Malchiodi; Edoardo Picetti; Roberto Menozzi; Sandra Rossi
Journal:  SN Compr Clin Med       Date:  2020-07-04

3.  Adequacy of physician clinical rounds and nursing care elements for non-COVID-19 infected patients admitted during the COVID-19 pandemic.

Authors:  Abdullah Alrasheed; Jinan Shamou; Rajkumar Rajendram; Abdulaziz Boqaeid; Salman Qasim; Waleed Baharoon; Laila Layqah; Salim Baharoon
Journal:  J Infect Public Health       Date:  2022-04-28       Impact factor: 7.537

4.  Stroke management during the coronavirus disease 2019 (COVID-19) pandemic: experience from three regions of the north east of Italy (Veneto, Friuli-Venezia-Giulia, Trentino-Alto-Adige).

Authors:  Paolo Manganotti; Marcello Naccarato; Ilario Scali; Manuel Cappellari; Bruno Bonetti; Alessandro Burlina; Emanuele Turinese; Sabrina Bogo; Francesco Teatini; Enrica Franchini; Giorgio Caneve; Giampietro Ruzza; Anna Gaudenzi; Roberto Bombardi; Giulio Bozzato; Roberta Padoan; Carolina Gentile; Michele Rana; Michelangelo Turazzini; Danese Alessandra; Francesco Brigo; Raffaele Nardone; Rocco Quatrale; Elisabetta Menegazzo; Maela Masato; Stefano Novello; Paolo Passadore; Antonio Baldi; Luca Valentinis; Claudio Baracchini; Alessio Pieroni; Anna Maria Basile; Claudio Semplicini; Silvio Piffer; Bruno Giometto; Simone Tonello; Domenico Marco Bonifatti; Simone Lorenzut; Giovanni Merlino; Maria Rosaria Valente; Francesco Paladin; Agnese Tonon; Cristina de Luca; Francesco Perini; Sandro Centonze; Paolo Bovi
Journal:  Neurol Sci       Date:  2021-03-04       Impact factor: 3.307

Review 5.  Recommendations for the safety of hospitalised patients in the context of the COVID-19 pandemic: a scoping review.

Authors:  Maristela Santini Martins; Daniela Campos de Andrade Lourenção; Rafael Rodrigo da Silva Pimentel; Janine Melo de Oliveira; Letícia Tuany de Carvalho Nogueira Manganoti; Roberto Chrispim Modesto; Maiquele Sirlei Dos Santos Silva; Marcelo José Dos Santos
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.